|
End-of-day quote
Shenzhen S.E.
15/09/2026
|
5-day change | 1st Jan Change | ||
| 9.110 CNY | -3.09% |
|
-4.81% | -16.04% |
| Market Cap | 4.65B 693M 600M 568M 514M 964M 66.46B 972M 6.77B 2.61B 33.7B 2.6B 2.54B 107B | P/E 2024 |
224x | P/E 2025 | 67.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58B 682M 591M 559M 506M 949M 65.43B 956M 6.67B 2.56B 33.17B 2.56B 2.51B 106B | EV / Sales 2024 |
6.57x | EV / Sales 2025 | 5.78x |
| Free-Float |
59.54% | Yield 2024 |
0.56% | Yield 2025 | 1.38% |
| 1 day | -3.09% | ||
| 1 week | -4.81% | ||
| Current month | +2.36% | ||
| 1 month | -3.09% | ||
| 3 months | +8.84% | ||
| 6 months | -18.30% | ||
| Current year | -16.04% |
| 1 week | 8.96 |  | 9.57 |
| 1 month | 8.51 | | 9.74 |
| Current year | 7.66 | | 14.47 |
| 1 year | 7.66 | | 15.21 |
| 3 years | 6.79 | | 17.49 |
| 5 years | 5.64 | | 19.64 |
| 10 years | 5.01 | | 20.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rong Huang Xu
CEO | Chief Executive Officer | 34 | 15/07/2025 |
Xi Liang Chen
DFI | Director of Finance/CFO | 54 | 14/06/2009 |
Ru Qing Yao
PRN | Corporate Officer/Principal | 43 | 31/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Xi Liang Chen
BRD | Director/Board Member | 54 | 14/06/2009 |
Bei Jing Lu
BRD | Director/Board Member | 43 | 26/06/2022 |
Rong Huang Xu
CHM | Chairman | 34 | 15/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/02/24 | Buy | Chief Financial Officer | 42,000 | 0.0188% | ||
| 14/06/23 | Buy | Chief Financial Officer | 42,000 | 0.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.09% | -4.81% | +3.52% | -15.48% | 693M | |
| -0.19% | +1.09% | +51.85% | +97.36% | 1,013B | |
| +0.33% | -0.71% | +50.62% | +65.50% | 644B | |
| +0.49% | +5.73% | +20.88% | +72.92% | 465B | |
| -0.22% | +2.88% | +38.48% | +37.98% | 352B | |
| -0.07% | +1.82% | +16.57% | +23.39% | 264B | |
| -0.31% | +2.02% | +6.15% | +10.75% | 253B | |
| -1.53% | -4.46% | +36.90% | +44.08% | 203B | |
| -1.60% | -5.51% | -22.30% | -58.60% | 188B | |
| +0.49% | -0.23% | +30.00% | +93.34% | 181B | |
| Average | -0.38% | -1.34% | +23.27% | +37.12% | 356.44B | |
| Weighted average by Cap. | +0.40% | +0.01% | +34.51% | +59.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 688M 102M 88.72M 83.89M 75.95M 143M 9.82B 144M 1B 385M 4.98B 385M 376M 15.89B | 925M 138M 119M 113M 102M 192M 13.21B 193M 1.35B 518M 6.7B 517M 506M 21.36B |
| Net income | 20.5M 3.05M 2.64M 2.5M 2.26M 4.25M 293M 4.28M 29.83M 11.48M 148M 11.46M 11.21M 473M | 81.67M 12.16M 10.53M 9.96M 9.02M 16.93M 1.17B 17.05M 119M 45.74M 592M 45.68M 44.67M 1.89B |
| Net Debt | 58.68M 8.74M 7.57M 7.16M 6.48M 12.16M 838M 12.25M 85.41M 32.86M 425M 32.82M 32.1M 1.36B | -72.61M -10.81M -9.37M -8.86M -8.02M -15.05M -1.04B -15.16M -106M -40.66M -526M -40.62M -39.71M -1.68B |
Employees
1,434
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | CN¥9.110 | -3.09% | 14,885,544 |
| 14/09/26 | CN¥9.400 | +3.41% | 18,905,068 |
| 11/09/26 | CN¥9.090 | -1.62% | 13,084,383 |
| 10/09/26 | CN¥9.240 | -2.22% | 12,205,216 |
| 09/09/26 | CN¥9.450 | -1.25% | 16,512,572 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002728 Stock
Select your edition
All financial news and data tailored to specific country editions
